...
机译:漂亮的删除和抵抗屋顶漂亮/兆欧抑制剂治疗
Department of Medicine Vanderbilt University Medical Center Nashville TN USA;
Department of Medicine Vanderbilt University Medical Center Nashville TN USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Department of Medicine Vanderbilt University Medical Center Nashville TN USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Foundation Medicine Inc. Cambridge MA USA;
Northwestern University Medical Center Chicago IL USA;
Department of Medicine Vanderbilt University Medical Center Nashville TN USA;
BRAF; dabrafenib; internal deletion; rearrangement; resistance; trametinib; vemurafenib;
机译:漂亮的删除和抵抗屋顶漂亮/兆欧抑制剂治疗
机译:立体定向放射外科手术和抗PD-1治疗,抗CTLA-4治疗,BRAF / MEK抑制剂,BRAF抑制剂或常规化疗治疗的黑色素瘤脑转移的临床结局
机译:同时发生MEK2突变和BRAF扩增赋予黑色素瘤对BRAF和MEK抑制剂的抗性。
机译:黑色素瘤中BRAF抑制剂抗性的基因表达模型预测了新型组合疗法的药物重新培养候选者
机译:黑色瘤中BRAF均含量抗性的机制抑制剂抗性
机译:BRAF内部缺失和对BRAF / MEK抑制剂治疗的耐药性
机译:漂亮的删除和抵抗屋顶尼斯/梅克抑制剂治疗